Skip to main content
Premium Trial:

Request an Annual Quote

Ian Heynen

Ian Heynen has been named general manager of Sysmex Canada, a wholly owned subsidiary of Sysmex America. He will execute the firm's business strategy in the Canadian market and will report to Sysmex Canada CEO Andy Hay. Heynen was most recetly senior vice president of sales and marketing for Profound Medical. Prior to that he was acting president of the international division of Hologic. 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.